indomethacin has a weak antiviral activity against sars coronavirus
indomethacin has a weak antiviral activity against sars coronavirus
conclusions: the results identify indo as a potent inhibitor of coronavirus replication and suggest that, having both anti-inflammatory and antiviral activity, indo could be beneficial in sars therapy.", "results: unexpectedly, we found that indo has a potent direct antiviral activity against the coronaviruses sars-cov and ccov.")